Clinical characteristics | Mirena group N (%) (n = 25) | Metformin group N (%) (n = 25) | Test value | p-value |
---|---|---|---|---|
Side effects | ||||
Absent | 10 (40%) | 12 (48%) | 0.35 | 0.50a |
Present | 15 (60%) | 13 (52%) | ||
Adverse eventsc | ||||
GIT upset | 0 (0) | 9 (36%) | 9.6 | 0.004b |
Heavy bleeding at first use | 2 (8%) | 0 (0) | 2.1 | 0.5b |
Abdominal/pelvic pain | 5 (20%) | 3 (12%) | 0.8 | 0.7b |
Hypoglycemia | 0 (0) | 4 (16%) | 4.3 | 0.1b |
Nervousness | 2 (8%) | 0 (0) | 2.1 | 0.5b |
Depression | 2 (8%) | 0 (0) | 2.1 | 0.5b |
Headache | 4 (16%) | 0 (0) | 4.3 | 0.1b |
Back pain | 4 (16%) | 0 (0) | 4.3 | 0.1b |
Myalgia | 0 (0) | 2 (8%) | 2.1 | 0.5b |
Weight gain | 2 (8%) | 0 (0) | 2.1 | 0.5b |
Breast tenderness | 3 (12%) | 0 (0) | 2.1 | 0.5b |